X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1143) 1143
Publication (104) 104
Book Chapter (23) 23
Book Review (13) 13
Conference Proceeding (9) 9
Dissertation (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (930) 930
hyperphosphatemia (681) 681
index medicus (565) 565
male (491) 491
urology & nephrology (467) 467
female (426) 426
hyperphosphatemia - etiology (345) 345
middle aged (331) 331
kidney failure, chronic - complications (296) 296
hyperphosphatemia - drug therapy (254) 254
aged (252) 252
hemodialysis-patients (230) 230
adult (213) 213
chronic kidney-disease (205) 205
phosphates - blood (200) 200
calcium (189) 189
hemodialysis (185) 185
renal dialysis (185) 185
mortality (177) 177
chronic kidney disease (176) 176
kidney failure, chronic - therapy (172) 172
sevelamer (170) 170
phosphorus (164) 164
animals (163) 163
hyperphosphatemia - complications (162) 162
renal insufficiency, chronic - complications (160) 160
risk factors (158) 158
stage renal-disease (155) 155
treatment outcome (152) 152
hyperphosphatemia - blood (149) 149
nephrology (148) 148
phosphorus - blood (147) 147
phosphate (145) 145
vascular calcification (145) 145
chelating agents - therapeutic use (142) 142
dialysis (141) 141
phosphates (134) 134
dialysis patients (131) 131
calcification (128) 128
secondary hyperparathyroidism (126) 126
calcium - blood (118) 118
parathyroid-hormone (118) 118
kidney diseases (117) 117
parathyroid hormone - blood (112) 112
phosphates - metabolism (110) 110
chronic kidney failure (104) 104
mineral metabolism (103) 103
phosphate binder (99) 99
phosphate binders (99) 99
chronic-renal-failure (98) 98
parathyroid hormone (98) 98
lanthanum carbonate (94) 94
serum phosphorus (94) 94
coronary-artery calcification (90) 90
kidney failure, chronic - blood (90) 90
calcinosis - etiology (88) 88
hyperparathyroidism (85) 85
polyamines - therapeutic use (84) 84
renal dialysis - adverse effects (84) 84
lanthanum - therapeutic use (82) 82
hyperparathyroidism, secondary - etiology (79) 79
hyperphosphatemia - prevention & control (79) 79
hyperphosphatemia - metabolism (78) 78
medicine, general & internal (78) 78
vitamin d (77) 77
hypocalcemia (76) 76
care and treatment (74) 74
kidney diseases - complications (74) 74
rats (74) 74
sevelamer hydrochloride (74) 74
chronic disease (69) 69
disease (69) 69
aged, 80 and over (68) 68
health aspects (68) 68
time factors (68) 68
cardiovascular diseases - etiology (67) 67
cardiovascular-disease (66) 66
biomarkers - blood (63) 63
pharmacology & pharmacy (62) 62
hyperphosphatemia - therapy (61) 61
transplantation (61) 61
medicine & public health (60) 60
prospective studies (60) 60
mortality risk (58) 58
phosphates - adverse effects (58) 58
hyperphosphatemia - diagnosis (57) 57
metabolism (57) 57
renal insufficiency, chronic - blood (57) 57
calcium-carbonate (56) 56
hyperparathyroidism, secondary - drug therapy (56) 56
maintenance hemodialysis (56) 56
pediatrics (56) 56
renal insufficiency, chronic - therapy (56) 56
child (55) 55
calcium carbonate (54) 54
growth-factor 23 (54) 54
chelating agents - adverse effects (51) 51
research (51) 51
vitamin-d (51) 51
diet (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1030) 1030
Japanese (29) 29
German (22) 22
French (21) 21
Spanish (21) 21
Italian (7) 7
Polish (7) 7
Russian (7) 7
Korean (5) 5
Portuguese (3) 3
Chinese (1) 1
Croatian (1) 1
Finnish (1) 1
Hungarian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Society of Nephrology, ISSN 1046-6673, 01/2009, Volume 20, Issue 1, pp. 164 - 171
Journal Article
Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 12/2018, Volume 47, Issue 4, pp. 771 - 782
Journal Article
Clinical Kidney Journal, ISSN 2048-8505, 08/2017, Volume 10, Issue 4, pp. 539 - 544
Abstract Background Sevelamer is a phosphate binder widely used in chronic kidney disease (CKD) patients. Sevelamer, as well as other resin-based binders, can... 
TRACT | chronic kidney disease | crystals | gastrointestinal lesions | MUCOSAL-INJURY | HYPERPHOSPHATEMIA | hyperphosphataemia | CALCIUM | UROLOGY & NEPHROLOGY | sevelamer | PHOSPHATE BINDERS | CHRONIC KIDNEY-DISEASE | CKD-Mbd
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 06/2010, Volume 24, Issue 3, pp. 553 - 565
A thorough working knowledge of the diagnosis and treatment of life-threatening electrolyte abnormalities in cancer patients, especially hyponatremia,... 
Hypercalcemia | Hyperphosphatemia | Electrolytes | Malignancy | Hyponatremia | Hypoglycemia | TUMOR-INDUCED HYPOGLYCEMIA | CENTRAL PONTINE MYELINOLYSIS | MANAGEMENT | SYMPTOMATIC HYPONATREMIA | RAPID CORRECTION | ONCOLOGY | INTENSIVE-CARE-UNIT | SERUM SODIUM | PATIENT | OF-THE-LITERATURE | HEMATOLOGY
Journal Article
Journal Article
Nephrologie et Therapeutique, ISSN 1769-7255, 11/2018, Volume 14, Issue 6, pp. 6S17 - 6S25
Metabolic complications of chronic kidney disease (CKD) are frequent; the aims of this review are to present a 2018 update for hyperkalemia, hyperphosphatemia... 
Hyperkalemia | Anemia | Hyperphosphatemia | Chronic kidney disease
Journal Article
Nephrologie et Thérapeutique, ISSN 1769-7255, 11/2018, Volume 14, Issue 6, pp. 6S17 - 6S25
Les complications métaboliques de la maladie rénale chronique (MRC) sont fréquentes, parmi lesquelles l’hyperphosphatémie, l’hyperkaliémie et l’anémie.... 
Hyperkalemia | Hyperphosphatémie | Hyperkaliémie | Insuffisance rénale chronique | Anemia | Hyperphosphatemia | Anémie | Chronic kidney disease
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 11/2004, Volume 66, Issue 5, pp. 2022 - 2031
Journal Article
Pediatric Nephrology, ISSN 0931-041X, 4/2010, Volume 25, Issue 4, pp. 769 - 778
Journal Article